MEK inhibitors induce Akt activation and drug resistance by suppressing negative feedback ERK‐mediated HER2 phosphorylation at Thr701

Targeting the MEK/ERK pathway has been viewed as a promising strategy for cancer therapy. However, MEK inhibition leads to the compensatory PI3K/AKT activation and thus contributes to the desensitization of cancer cells to MEK inhibitors. The underlying molecular mechanism of this event is not yet u...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mol Oncol
Egile Nagusiak: Chen, Chia‐Hung, Hsia, Te‐Chun, Yeh, Ming‐Hsin, Chen, Tsung‐Wei, Chen, Yun‐Ju, Chen, Jung‐Tsu, Wei, Ya‐Ling, Tu, Chih‐Yen, Huang, Wei‐Chien
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2017
Gaiak:
Research Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5579385/
https://ncbi.nlm.nih.gov/pubmed/28632938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12102
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak